ClinVar Miner

Submissions for variant NM_000053.4(ATP7B):c.3556+1G>T (rs184388696)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000587514 SCV000694450 likely pathogenic Wilson disease 2017-05-25 criteria provided, single submitter clinical testing Variant summary: The ATP7B c.3556+1G>T variant involves the alteration of a conserved intronic nucleotide. One in silico tool predicts a damaging outcome for this variant. 3/5 splice prediction tools predict a significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant was identified in 3 Wilson disease patients of Turkish descent (Karunas_Genetika_2000; Karunas_Russian J of Med Genet_2009; Khidiyatova_Conf paper). This variant is absent from the large control database ExAC (0/120768 control chromosomes). In addition, the variant has been reported by the University of Alberta Wilson Disease database and is classified as pathogenic. Variant involves the same neucleotide c.3556+1G>A has been classififed as likely pathgoenic by our lab. Taken together, this variant is classified as likely pathogenic until more evidence becomes available.
Counsyl RCV000587514 SCV000791699 likely pathogenic Wilson disease 2017-05-26 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.